The participation of non-canonical autophagic proteins in the autophagy process and their potential as therapeutic targets

References

• Green DR, Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell. 2014;157(1):65–75.
   PubMed Web of Science ®Google Scholar
• Feng Y, He D, Yao Z, et al. The machinery of macroautophagy. Cell Res. 2014;24(1):24–41.
   PubMed Web of Science ®Google Scholar
• Rogov V, Dötsch V, Johansen T, et al. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell. 2014;53(2):167–178.
   PubMed Web of Science ®Google Scholar
• Xia H, Green DR, Zou W. Autophagy in tumour immunity and therapy. Nat Rev Cancer. 2021;21(5):281–297.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728–741.
   PubMed Web of Science ®Google Scholar
• Djajadikerta A, Keshri S, Pavel M, et al. Autophagy induction as a therapeutic strategy for neurodegenerative diseases. J Mol Biol. 2020;432(8):2799–2821.
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17(9):528–542.
   PubMed Web of Science ®Google Scholar
• Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3–12.
   PubMed Web of Science ®Google Scholar
• Li WW, Li J, Bao JK. Microautophagy: lesser-known self-eating. Cell Mol Life Sci. 2012;69(7):1125–1136.
   PubMed Web of Science ®Google Scholar
• Müller O, Sattler T, Flötenmeyer M, et al. Autophagic tubes: vacuolar invaginations involved in lateral membrane sorting and inverse vesicle budding. J Cell Biol. 2000;151(3):519–528.
   PubMed Web of Science ®Google Scholar
• Kaushik S, Cuervo AM. The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol. 2018;19(6):365–381.
   PubMed Web of Science ®Google Scholar
• Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19(6):349–364.
   PubMed Web of Science ®Google Scholar
• Shibutani ST, Saitoh T, Nowag H, et al. Autophagy and autophagy-related proteins in the immune system. Nat Immunol. 2015;16(10):1014–1024.
   PubMed Web of Science ®Google Scholar
• Tsukada M, Ohsumi Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett. 1993;333(1–2):169–174.
   PubMed Web of Science ®Google Scholar
• Lamark T, Svenning S, Johansen T. Regulation of selective autophagy: the p62/SQSTM1 paradigm. Essays Biochem. 2017;61(6):609–624.
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Kumanomidou T, Sou Y-S, et al. Structural basis for sorting mechanism of p62 in selective autophagy. J Biol Chem. 2008;283(33):22847–22857.
   PubMed Web of Science ®Google Scholar
• Kirkin V, Rogov VV. A diversity of selective autophagy receptors determines the specificity of the autophagy pathway. Mol Cell. 2019;76(2):268–285.
   PubMed Web of Science ®Google Scholar
• Soubannier V, G-L M, Zunino R, et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr Biol. 2012;22(2):135–141.
   PubMed Web of Science ®Google Scholar
• Chino H, Mizushima N. ER-phagy: quality control and turnover of endoplasmic reticulum. Trends Cell Biol. 2020;30(5):384–398.
   PubMed Web of Science ®Google Scholar
• Singh R, Kaushik S, Wang Y, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131–1135.
   PubMed Web of Science ®Google Scholar
• Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12(8):1425–1428.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Cuervo AM, et al. Autophagy fights disease through cellular self-digestion. Nature. 2008;451(7182):1069–1075.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Petroni G, Amaravadi RK, et al. Autophagy in major human diseases. EMBO J. 2021;40(19):e108863.
   PubMed Web of Science ®Google Scholar
• Kaeberlein M, Galvan V. Rapamycin and Alzheimer’s disease: time for a clinical trial? Sci Transl Med. 2019;11(476):eaar4289.
   PubMed Web of Science ®Google Scholar
• Querfurth H, Lee H-K. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener. 2021;16(1):44.
   PubMed Web of Science ®Google Scholar
• Patlolla JM, Kopelovich L, Qian L, et al. Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice. Oncol Rep. 2015;34(6):2925–2934.
   PubMed Web of Science ®Google Scholar
• Mauthe M, Orhon I, Rocchi C, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435–1455.
   PubMed Web of Science ®Google Scholar
• Manic G, Obrist F, Kroemer G, et al. Chloroquine and hydroxychloroquine for cancer therapy. Mol Cell Oncol. 2014;1(1):e29911.
   PubMedGoogle Scholar
• Eng CH, Wang Z, Tkach D, et al. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc Natl Acad Sci U S A. 2016;113(1):182–187.
   PubMed Web of Science ®Google Scholar
• Xu R, Ji Z, Xu C, et al. The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97(46):e12912.
   PubMed Web of Science ®Google Scholar
• Sessa C, Tosi D, Viganò L, et al. Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel. Ann Oncol. 2010;21(6):1315–1322.
   PubMed Web of Science ®Google Scholar
• Schreiber KH, Arriola Apelo SI, Yu D, et al. A novel rapamycin analog is highly selective for mTORC1 in vivo. Nat Commun. 2019;10(1):3194.
   PubMedGoogle Scholar
• Rizzieri DA, Feldman E, DiPersio JF, et al. A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res. 2008;14(9):2756–2762.
   PubMed Web of Science ®Google Scholar
• Liu Q, Tang Z, Surdenikova L, et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-Induced pruritus. Cell. 2009;139(7):1353–1365.
   PubMed Web of Science ®Google Scholar
• Mossmann D, Park S, Hall MN. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer. 2018;18(12):744–757.
   PubMed Web of Science ®Google Scholar
• Bar-Peled L, Sabatini DM. Regulation of mTORC1 by amino acids. Trends Cell Biol. 2014;24(7):400–406.
   PubMed Web of Science ®Google Scholar
• Hua H, Kong Q, Zhang H, et al. Targeting mTOR for cancer therapy. J Hematol Oncol. 2019;12(1):71.
   PubMed Web of Science ®Google Scholar
• Liu X, Chhipa RR, Pooya S, et al. Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. Proc Nat Acad Sci. 2014;111(4):E435–E444.
   PubMed Web of Science ®Google Scholar
• Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008;30(2):214–226.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Baehrecke EH, Brumell JH, et al. A comprehensive glossary of autophagy-related molecules and processes 2nd. Autophagy. 2011;7(11):1273–1294.
   PubMed Web of Science ®Google Scholar
• Hosokawa N, Hara T, Kaizuka T, et al. Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy. Mol Biol Cell. 2009;20(7):1981–1991.
   PubMed Web of Science ®Google Scholar
• Dossou AS, Basu A. The emerging roles of mTORC1 in macromanaging autophagy. Cancers (Basel). 2019;11(10):1422.
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell. 2009;20(7):1992–2003.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141.
   PubMed Web of Science ®Google Scholar
• Puente C, Hendrickson RC, Nutrient-regulated JX. Phosphorylation of ATG13 Inhibits Starvation-induced Autophagy. J Biol Chem. 2016;291(11):6026–6035.
   PubMed Web of Science ®Google Scholar
• Egan DF, Chun MG, Vamos M, et al. Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates. Mol Cell. 2015;59(2):285–297.
   PubMed Web of Science ®Google Scholar
• Bach M, Larance M, James DE, et al. The serine/threonine kinase ULK1 is a target of multiple phosphorylation events. Biochem J. 2011;440(2):283–291.
   PubMed Web of Science ®Google Scholar
• Zachari M, Ganley IG. The mammalian ULK1 complex and autophagy initiation. Essays Biochem. 2017;61(6):585–596.
   PubMed Web of Science ®Google Scholar
• Mercer TJ, Gubas A, Tooze SA. A molecular perspective of mammalian autophagosome biogenesis. J Biol Chem. 2018;293(15):5386–5395.
   PubMed Web of Science ®Google Scholar
• Fogel AI, Dlouhy BJ, Wang C, et al. Role of membrane association and ATG14-dependent phosphorylation in beclin-1-mediated autophagy. Mol Cell Biol. 2013;33(18):3675–3688.
   PubMed Web of Science ®Google Scholar
• Russell RC, Tian Y, Yuan H, et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol. 2013;15(7):741–750.
   PubMed Web of Science ®Google Scholar
• Polson HE, de Lartigue J, Rigden DJ, et al. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy. 2010;6(4):506–522.
   PubMed Web of Science ®Google Scholar
• Dooley HC, Razi M, Polson HE, et al. WIPI2 links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12-5-16L1. Mol Cell. 2014;55(2):238–252.
   PubMed Web of Science ®Google Scholar
• Runwal G, Stamatakou E, Siddiqi FH, et al. LC3-positive structures are prominent in autophagy-deficient cells. Sci Rep. 2019;9(1):10147.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Green DR. Autophagy-independent functions of the autophagy machinery. Cell. 2019;177(7):1682–1699.
   PubMed Web of Science ®Google Scholar
• Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013 Aug;19(8):983–997.
   PubMed Web of Science ®Google Scholar
• Bai B, Wang X, Li Y, et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer’s disease progression. Neuron. 2020;105(6):975–991 e7.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441(7095):880–884.
   PubMed Web of Science ®Google Scholar
• Nilsson P, Loganathan K, Sekiguchi M, et al. Abeta secretion and plaque formation depend on autophagy. Cell Rep. 2013;5(1):61–69.
   PubMed Web of Science ®Google Scholar
• Choi I, Zhang Y, Seegobin SP, et al. Microglia clear neuron-released alpha-synuclein via selective autophagy and prevent neurodegeneration. Nat Commun. 2020;11(1):1386.
   PubMed Web of Science ®Google Scholar
• Heckmann BL, Teubner BJW, Boada-Romero E, et al. Noncanonical function of an autophagy protein prevents spontaneous Alzheimer’s disease. Sci Adv. 2020;6(33):eabb9036.
   PubMed Web of Science ®Google Scholar
• Scrivo A, Bourdenx M, Pampliega O, et al. Selective autophagy as a potential therapeutic target for neurodegenerative disorders. Lancet Neurol. 2018;17(9):802–815.
   PubMed Web of Science ®Google Scholar
• Shirakabe A, Ikeda Y, Sciarretta S, et al. Aging and autophagy in the heart. Circ Res. 2016;118(10):1563–1576.
   PubMed Web of Science ®Google Scholar
• Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature. 2000;406(6798):906–910.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Guhde G, Suter A, et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature. 2000;406(6798):902–906.
   PubMed Web of Science ®Google Scholar
• Tong M, Saito T, Zhai P, et al. Mitophagy is essential for maintaining cardiac function during high fat diet-induced diabetic cardiomyopathy. Circ Res. 2019;124(9):1360–1371.
   PubMed Web of Science ®Google Scholar
• Zhao W, Li Y, Jia L, et al. Atg5 deficiency-mediated mitophagy aggravates cardiac inflammation and injury in response to angiotensin II. Free Radic Biol Med. 2014;69:108–115.
   PubMed Web of Science ®Google Scholar
• Vion AC, Kheloufi M, Hammoutene A, et al. Autophagy is required for endothelial cell alignment and atheroprotection under physiological blood flow. Proc Natl Acad Sci U S A. 2017;114(41):E8675–E8684.
   PubMed Web of Science ®Google Scholar
• Das CK, Banerjee I, Mandal M. Pro-survival autophagy: an emerging candidate of tumor progression through maintaining hallmarks of cancer. Semin Cancer Biol. 2020;66:59–74.
   PubMed Web of Science ®Google Scholar
• Rosenfeldt MT, O’Prey J, Morton JP, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature. 2013;504(7479):296–300.
   PubMed Web of Science ®Google Scholar
• Takamura A, Komatsu M, Hara T, et al. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011;25(8):795–800.
   PubMed Web of Science ®Google Scholar
• White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer. 2012;12(6):401–410.
   PubMed Web of Science ®Google Scholar
• Yang S, Wang X, Contino G, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011;25(7):717–729.
   PubMed Web of Science ®Google Scholar
• Abedin MJ, Wang D, McDonnell MA, et al. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 2007;14(3):500–510.
   PubMed Web of Science ®Google Scholar
• Lens SM, Voest EE, Medema RH. Shared and separate functions of polo-like kinases and Aurora kinases in cancer. Nat Rev Cancer. 2010;10(12):825–841.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang X. Kinases involved in both autophagy and mitosis. Int J Mol Sci. 2017;18(9):1884.
   PubMed Web of Science ®Google Scholar
• Combes G, Alharbi I, Braga LG, et al. Playing polo during mitosis: PLK1 takes the lead. Oncogene. 2017;36(34):4819–4827.
   PubMed Web of Science ®Google Scholar
• BCMvd W, Medema RH. Polo-like kinases: a team in control of the division. Cell Cycle. 2006;5(8):853–864.
   PubMed Web of Science ®Google Scholar
• Deeraksa A, Pan J, Sha Y, et al. Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis. Oncogene. 2013;32(24):2973–2983.
   PubMed Web of Science ®Google Scholar
• Valianou M, Cox AM, Pichette B, et al. Pharmacological inhibition of Polo-like kinase 1 (PLK1) by BI-2536 decreases the viability and survival of hamartin and tuberin deficient cells via induction of apoptosis and attenuation of autophagy. Cell Cycle. 2015;14(3):399–407.
   PubMed Web of Science ®Google Scholar
• Ruf S, Heberle AM, Langelaar-Makkinje M, et al. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy. Autophagy. 2017;13(3):486–505.
   PubMed Web of Science ®Google Scholar
• Luo P, Yan H, Du J, et al. PLK1 (polo like kinase 1)-dependent autophagy facilitates gefitinib-induced hepatotoxicity by degrading COX6A1 (cytochrome c oxidase subunit 6A1). Autophagy. 2021;17(10):3221–3237.
   PubMed Web of Science ®Google Scholar
• Schiltz RL, Mizzen CA, Vassilev A, et al. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem. 1999;274(3):1189–1192.
   PubMed Web of Science ®Google Scholar
• Soutoglou E, Viollet B, Vaxillaire M, et al. Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J. 2001;20(8):1984–1992.
   PubMed Web of Science ®Google Scholar
• Xu L, Glass CK, Rosenfeld MG. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev. 1999;9(2):140–147.
   PubMed Web of Science ®Google Scholar
• Jia Y-L, Xu M, Dou C-W, et al. P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy. Cell Death Dis. 2016;7(10):e2400–e2400.
   PubMedGoogle Scholar
• Zheng X, Gai X, Ding F, et al. Histone acetyltransferase PCAF up-regulated cell apoptosis in hepatocellular carcinoma via acetylating histone H4 and inactivating AKT signaling. Mol Cancer. 2013;12(1):96.
   PubMedGoogle Scholar
• Kong D, Ying B, Zhang J, et al. PCAF regulates H3 phosphorylation and promotes autophagy in osteosarcoma cells. Biomed Pharmacother. 2019;118:109395.
   PubMed Web of Science ®Google Scholar
• Qiu L, Xu C, Xia H, et al. Downregulation of P300/CBP-associated factor attenuates myocardial ischemia-reperfusion injury via inhibiting autophagy [research paper]. International Journal of Medical Sciences. 2020;17(9):1196–1206.
   Google Scholar
• Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem. 2007;388(12):1257–1274.
   PubMed Web of Science ®Google Scholar
• Gartel AL. FOXM1 in Cancer: interactions and Vulnerabilities. Cancer Res. 2017;77(12):3135–3139.
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu Y, Yuan B, et al. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription. Oncotarget. 2017;8(10):17027–17037.
   PubMedGoogle Scholar
• Pan H, Zhu Y, Wei W, et al. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer. World J Surg Oncol. 2018;16(1):59.
   PubMedGoogle Scholar
• Hamurcu Z, Delibaşı N, Nalbantoglu U, et al. FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells. J Mol Med. 2019;97(4):491–508.
   PubMed Web of Science ®Google Scholar
• Lin J-Z, Wang W-W, Hu T-T, et al. FOXM1 contributes to docetaxel resistance in castration-resistant prostate cancer by inducing AMPK/mTOR-mediated autophagy. Cancer Lett. 2020;469:481–489.
   PubMed Web of Science ®Google Scholar
• Yang H, Yang T, Baur JA, et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell. 2007;130(6):1095–1107.
   PubMed Web of Science ®Google Scholar
• Hsu C-P, Oka S, Shao D, et al. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res. 2009;105(5):481–491.
   PubMed Web of Science ®Google Scholar
• Wang P, Guan Y-F, Du H, et al. Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia. Autophagy. 2012;8(1):77–87.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–872.
   PubMed Web of Science ®Google Scholar
• Sharif T, Martell E, Dai C, et al. Autophagic homeostasis is required for the pluripotency of cancer stem cells. Autophagy. 2017;13(2):264–284.
   PubMed Web of Science ®Google Scholar
• Stirparo GG, Kurowski A, Yanagida A, et al. OCT4 induces embryonic pluripotency via STAT3 signaling and metabolic mechanisms. Proc Nat Acad Sci. 2021;118(3):e2008890118.
   PubMed Web of Science ®Google Scholar
• Jarnagin K, Grunberger D, Mulkins M, et al. Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. Biochemistry. 1999;38(49):16167–16177.
   PubMed Web of Science ®Google Scholar
• Rollins BJ. Chemokines. Blood. 1997;90(3):909–928.
   PubMed Web of Science ®Google Scholar
• Lim SY, Yuzhalin AE, Gordon-Weeks AN, et al. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget. 2016;7:19.
   Google Scholar
• Roca H, Varsos Z, Pienta KJ. CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation. J Biol Chem. 2008;283(36):25057–25073.
   PubMed Web of Science ®Google Scholar
• Roca H, Varsos ZS, Pienta KJ. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells. Neoplasia. 2009;11(12):1309–1317.
   PubMed Web of Science ®Google Scholar
• Fang WB, Yao M, Jokar I, et al. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Res Treat. 2015;150(2):309–320.
   PubMed Web of Science ®Google Scholar
• Xu W, Wei Q, Han M, et al. CCL2-SQSTM1 positive feedback loop suppresses autophagy to promote chemoresistance in gastric cancer. Int J Biol Sci. 2018;14(9):1054–1066.
   PubMed Web of Science ®Google Scholar
• Marumoto T, Hirota T, Morisaki T, et al. Roles of Aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells. Genes Cells. 2002;7(11):1173–1182.
   PubMed Web of Science ®Google Scholar
• Crane R, Gadea B, Littlepage L, et al. Aurora A, meiosis and mitosis. Biol Cell. 2004;96(3):215–229.
   PubMed Web of Science ®Google Scholar
• Xu LZ, Long ZJ, Peng F, et al. Aurora kinase a suppresses metabolic stress-induced autophagic cell death by activating mTOR signaling in breast cancer cells. Oncotarget. 2014;5(17):7498–7511.
   PubMedGoogle Scholar
• Ding YH, Zhou ZW, Ha CF, et al. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells. Drug Des Devel Ther. 2015;9:425–464.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang F, Zhou ZW, et al. Alisertib induces G(2)/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells. Am J Transl Res. 2017;9(3):845–873.
   PubMed Web of Science ®Google Scholar
• Wang F, Li H, Yan XG, et al. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells. Drug Des Devel Ther. 2015;9:575–601.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Yu X, Zhou ZW, et al. Inhibition of aurora a kinase by alisertib induces autophagy and cell cycle arrest and increases chemosensitivity in human hepatocellular carcinoma HepG2 cells. Curr Cancer Drug Targets. 2017;17(4):386–401.
   PubMed Web of Science ®Google Scholar
• Ren B-J, Zhou Z-W, Zhu D-J, et al. Alisertib induces cell cycle arrest, apoptosis, autophagy and suppresses EMT in HT29 and Caco-2 cells. Int J Mol Sci. 2016;17(1):41.
   Web of Science ®Google Scholar
• Jin L, Galonek H, Israelian K, et al. Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3. Protein Sci. 2009;18(3):514–525.
   PubMed Web of Science ®Google Scholar
• Park S-H, Ozden O, Jiang H, et al. Sirt3, mitochondrial ROS, ageing, and carcinogenesis. Int J Mol Sci. 2011;12(9):6226–6239.
   PubMed Web of Science ®Google Scholar
• Li J, Chen T, Xiao M, et al. Mouse Sirt3 promotes autophagy in AngII-induced myocardial hypertrophy through the deacetylation of FoxO1. Oncotarget. 2016;7(52):86648–86659.
   PubMedGoogle Scholar
• Dai S-H, Chen T, Li X, et al. Sirt3 confers protection against neuronal ischemia by inducing autophagy: involvement of the AMPK-mTOR pathway. Free Radic Biol Med. 2017;108:345–353.
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang L, Chen R, et al. SIRT3 protects against acute kidney injury via AMPK/mTOR-regulated autophagy. Front Physiol. 2018;9:1526.
   PubMed Web of Science ®Google Scholar
• Zhang T, Liu J, Shen S, et al. SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity. Cell Death Differ. 2020;27(1):329–344.
   PubMed Web of Science ®Google Scholar
• Li S, Dou X, Ning H, et al. Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity. Hepatology. 2017;66(3):936–952.
   PubMed Web of Science ®Google Scholar
• Lev S, Ben Halevy D, Peretti D, et al. The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol. 2008;18(6):282–290.
   PubMed Web of Science ®Google Scholar
• Axe EL, Walker SA, Manifava M, et al. Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. J Cell Biol. 2008;182(4):685–701.
   PubMed Web of Science ®Google Scholar
• Graef M, Friedman JR, Graham C, et al. ER exit sites are physical and functional core autophagosome biogenesis components. Mol Biol Cell. 2013;24(18):2918–2931.
   PubMed Web of Science ®Google Scholar
• Zhao YG, Liu N, Miao G, et al. The ER contact proteins VAPA/B interact with multiple autophagy proteins to modulate autophagosome biogenesis. Curr Biol. 2018;28(8):1234–1245.e4.
   PubMed Web of Science ®Google Scholar
• Mao D, Lin G, Tepe B, et al. VAMP associated proteins are required for autophagic and lysosomal degradation by promoting a PtdIns4P-mediated endosomal pathway. Autophagy. 2019;15(7):1214–1233.
   PubMed Web of Science ®Google Scholar
• Cui J, Li Y, Zhu L, et al. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol. 2012;13(4):387–395.
   PubMed Web of Science ®Google Scholar
• Fiorentino L, Stehlik C, Oliveira V, et al. A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. J Biol Chem. 2002;277(38):35333–35340.
   PubMed Web of Science ®Google Scholar
• Lian YG, Zhao HY, Wang SJ, et al. NLRP4 is an essential negative regulator of fructose-induced cardiac injury in vitro and in vivo. Biomed Pharmacother. 2017;91:590–601.
   PubMed Web of Science ®Google Scholar
• Jounai N, Kobiyama K, Shiina M, et al. NLRP4 negatively regulates autophagic processes through an association with beclin1. J Immunol. 2011;186(3):1646–1655.
   PubMed Web of Science ®Google Scholar
• Eberle HB, Serrano RL, Füllekrug J, et al. Identification and characterization of a novel human plant pathogenesis-related protein that localizes to lipid-enriched microdomains in the Golgi complex. J Cell Sci. 2002;115(Pt 4):827–838.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Hao L, Huang W, et al. The golgi-associated plant pathogenesis-related protein GAPR-1 enhances type I interferon signaling pathway in response to toll-like receptor 4. Inflammation. 2016;39(2):706–717.
   PubMed Web of Science ®Google Scholar
• Shoji-Kawata S, Sumpter R, Leveno M, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013;494(7436):201–206.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zou Z, Sun D, et al. GLIPR2 is a negative regulator of autophagy and the BECN1-ATG14-containing phosphatidylinositol 3-kinase complex. Autophagy. 2020;17(10):2891–2904.
   PubMed Web of Science ®Google Scholar
• Gong S, Li Q, Jeter CR, et al. Regulation of NANOG in cancer cells. Mol Carcinog. 2015;54(9):679–687.
   PubMed Web of Science ®Google Scholar
• Grubelnik G, Boštjančič E, Pavlič A, et al. NANOG expression in human development and cancerogenesis. Exp Biol Med (Maywood). 2020;245(5):456–464.
   PubMed Web of Science ®Google Scholar
• Hambiliki F, Ström S, Zhang P, et al. Co-localization of NANOG and OCT4 in human pre-implantation embryos and in human embryonic stem cells. J Assist Reprod Genet. 2012;29(10):1021–1028.
   PubMed Web of Science ®Google Scholar
• Hoei-Hansen CE, Almstrup K, Nielsen JE, et al. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology. 2005;47(1):48–56.
   PubMed Web of Science ®Google Scholar
• Hasmim M, Janji B, Khaled M, et al. Cutting edge: NANOG activates autophagy under hypoxic stress by binding to BNIP3L promoter. J Immunol. 2017;198(4):1423–1428.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zheng Y, Zhang X, et al. BNIP3L/NIX-mediated mitophagy protects against ischemic brain injury independent of PARK2. Autophagy. 2017;13(10):1754–1766.
   PubMed Web of Science ®Google Scholar
• Bellot G, Garcia-Medina R, Gounon P, et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol. 2009;29(10):2570–2581.
   PubMed Web of Science ®Google Scholar
• Cao L, Chen F, Yang X, et al. Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages. BMC Evol Biol. 2014;14:10.
   PubMed Web of Science ®Google Scholar
• Wheatley SP, Hinchcliffe EH, Glotzer M, et al. CDK1 inactivation regulates anaphase spindle dynamics and cytokinesis in vivo. J Cell Biol. 1997;138(2):385–393.
   PubMed Web of Science ®Google Scholar
• Lew J, Winkfein RJ, Paudel HK, et al. Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. J Biol Chem. 1992;267(36):25922–25926.
   PubMed Web of Science ®Google Scholar
• Cortés N, Guzmán-Martínez L, Andrade V, et al. CDK5: a unique CDK and its multiple roles in the nervous system. J Alzheimers Dis. 2019;68(3):843–855.
   PubMed Web of Science ®Google Scholar
• Terada M, Yasuda H, Kogawa S, et al. Expression and activity of cyclin-dependent kinase 5/p35 in adult rat peripheral nervous system. J Neurochem. 1998;71(6):2600–2606.
   PubMed Web of Science ®Google Scholar
• Furuya T, Kim M, Lipinski M, et al. Negative regulation of Vps34 by Cdk mediated phosphorylation. Mol Cell. 2010;38(4):500–511.
   PubMed Web of Science ®Google Scholar
• Xia Q, Cai Y, Peng R, et al. The CDK1 inhibitor RO3306 improves the response of BRCA-pro fi cient breast cancer cells to PARP inhibition. Int J Oncol. 2014;44(3):735–744.
   PubMed Web of Science ®Google Scholar
• Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011;75(1):50–83.
   PubMed Web of Science ®Google Scholar
• Ronkina N, Kotlyarov A, Gaestel M. MK2 and MK3–a pair of isoenzymes? Front Biosci. 2008;13:5511–5521.
   PubMed Web of Science ®Google Scholar
• Szyniarowski P, Corcelle-Termeau E, Farkas T, et al. A comprehensive siRNA screen for kinases that suppress macroautophagy in optimal growth conditions. Autophagy. 2011;7(8):892–903.
   PubMed Web of Science ®Google Scholar
• Wei Y, An Z, Zou Z, et al. The stress-responsive kinases MAPKAPK2/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation. Elife. 2015;4:e05289.
   PubMed Web of Science ®Google Scholar
• Walsh MC, Lee J, Choi Y. Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol Rev. 2015;266(1):72–92.
   PubMed Web of Science ®Google Scholar
• Shi C-S, Kehrl JH. TRAF6 and A20 regulate lysine 63–linked ubiquitination of beclin-1 to control TLR4-induced autophagy. Sci Signal. 2010;3(123):ra42.
   PubMed Web of Science ®Google Scholar
• Nazio F, Strappazzon F, Antonioli M, et al. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat Cell Biol. 2013;15(4):406–416.
   PubMed Web of Science ®Google Scholar
• Linares Juan F, Duran A, Yajima T, et al. K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells. Mol Cell. 2013;51(3):283–296.
   PubMed Web of Science ®Google Scholar
• Pollak NM, Hoffman M, Goldberg IJ, et al. Krüppel-like factors: crippling and un-crippling metabolic pathways. JACC Basic Transl Sci. 2018;3(1):132–156.
   PubMedGoogle Scholar
• Tetreault M-P, Yang Y, Katz JP. Krüppel-like factors in cancer. Nat Rev Cancer. 2013;13(10):701–713.
   PubMed Web of Science ®Google Scholar
• Riz I, Hawley TS, Hawley RG. KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models. Oncotarget. 2015;6(17):14814–14831.
   PubMedGoogle Scholar
• Liu C, DeRoo EP, Stecyk C, et al. Impaired autophagy in mouse embryonic fibroblasts null for Krüppel-like Factor 4 promotes DNA damage and increases apoptosis upon serum starvation. Mol Cancer. 2015;14:101.
   PubMed Web of Science ®Google Scholar
• Hsieh PN, Zhou G, Yuan Y, et al. A conserved KLF-autophagy pathway modulates nematode lifespan and mammalian age-associated vascular dysfunction. Nat Commun. 2017;8(1):914.
   PubMedGoogle Scholar
• Guixé-Muntet S, de Mesquita FC, Vila S, et al. Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury. J Hepatol. 2017;66(1):86–94.
   PubMed Web of Science ®Google Scholar
• Salmon M, Spinosa M, Zehner ZE, et al. Klf4, Klf2, and Zfp148 activate autophagy-related genes in smooth muscle cells during aortic aneurysm formation. Physiol Rep. 2019;7(8):e14058.
   PubMed Web of Science ®Google Scholar
• Laha D, Deb M, Das H. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy. Autophagy. 2019;15(12):2063–2075.
   PubMed Web of Science ®Google Scholar
• Zwartjes CG, Jayne S, van den Berg DL, et al. Repression of promoter activity by CNOT2, a subunit of the transcription regulatory Ccr4-not complex. J Biol Chem. 2004;279(12):10848–10854.
   PubMed Web of Science ®Google Scholar
• Zheng X, Dumitru R, Lackford BL, et al. Cnot1, Cnot2, and Cnot3 maintain mouse and human ESC identity and inhibit extraembryonic differentiation. Stem Cells. 2012;30(5):910–922.
   PubMed Web of Science ®Google Scholar
• Ito K, Inoue T, Yokoyama K, et al. CNOT2 depletion disrupts and inhibits the CCR4-NOT deadenylase complex and induces apoptotic cell death. Genes Cells. 2011;16(4):368–379.
   PubMed Web of Science ®Google Scholar
• Jeong K, Kwon HY, Jeong MS, et al. CNOT2 promotes degradation of p62/SQSTM1 as a negative regulator in ATG5 dependent autophagy. Oncotarget. 2017;8(28):46034–46046.
   PubMedGoogle Scholar
• Lee J, Jung JH, Hwang J, et al. CNOT2 Is critically involved in atorvastatin induced apoptotic and autophagic cell death in non-small cell lung cancers. Cancers (Basel). 2019;11(10):1470.
   PubMed Web of Science ®Google Scholar
• Pelzer C, Kassner I, Matentzoglu K, et al. UBE1L2, a novel E1 enzyme specific for ubiquitin. J Biol Chem. 2007;282(32):23010–23014.
   PubMed Web of Science ®Google Scholar
• Bartke T, Pohl C, Pyrowolakis G, et al. Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. Mol Cell. 2004;14(6):801–811.
   PubMed Web of Science ®Google Scholar
• Jia R, Bonifacino JS. Negative regulation of autophagy by UBA6-BIRC6–mediated ubiquitination of LC3. eLife. 2019;8:e50034.
   PubMed Web of Science ®Google Scholar
• Novak D, Hüser L, Elton JJ, et al. SOX2 in development and cancer biology. Semin Cancer Biol. 2020;67(Pt 1):74–82.
   PubMedGoogle Scholar
• Cho -Y-Y, Kim DJ, Lee HS, et al. Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cells. PLOS ONE. 2013;8(2):e57172.
   PubMed Web of Science ®Google Scholar
• Wang S, Xia P, Ye B, et al. Transient activation of autophagy via Sox2-mediated suppression of mTOR is an important early step in reprogramming to pluripotency. Cell Stem Cell. 2013;13(5):617–625.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Huang S, Chen S, et al. SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial–mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer. Cell Death Dis. 2021;12(5):449.
   PubMed Web of Science ®Google Scholar
• Wang AH, Bertos NR, Vezmar M, et al. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol Cell Biol. 1999;19(11):7816–7827.
   PubMed Web of Science ®Google Scholar
• Cheng C, Yang J, Li S-W, et al. HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target. Cell Death Dis. 2021;12(2):137.
   PubMed Web of Science ®Google Scholar
• Shao C, Guo K, Xu L, et al. Senescence marker protein 30 inhibits tumor growth by reducing HDAC4 expression in non-small cell lung cancer. Transl Lung Cancer Res. 2021;10(12):4558–4573.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu J, Zhen J, et al. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int. 2014;86(4):712–725.
   PubMed Web of Science ®Google Scholar
• Du J, Ji Q, Dong L, et al. HDAC4 knockdown induces preeclampsia cell autophagy and apoptosis by miR-29b. Reprod Sci. 2021;28(2):334–342.
   PubMed Web of Science ®Google Scholar
• Wu H, Liu C, Yang Q, et al. MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4. Autophagy. 2020;16(4):683–697.
   PubMed Web of Science ®Google Scholar
• Yang D, Xiao C, Long F, et al. HDAC4 regulates vascular inflammation via activation of autophagy. Cardiovasc Res. 2018;114(7):1016–1028.
   PubMed Web of Science ®Google Scholar
• Kim H, Kim Y, Jeoung D. DDX53 promotes cancer stem cell-like properties and autophagy. Mol Cells. 2017;40(1):54–65.
   PubMed Web of Science ®Google Scholar
• Kim Y, Yeon M, Jeoung D. DDX53 regulates cancer stem cell-like properties by binding to SOX-2. Mol Cells. 2017;40(5):322–330.
   PubMed Web of Science ®Google Scholar
• Kim Y, Park ST, Lee JJ. DDX53/miRNAs network regulates stemness and anti-cancer drug resistance by activating autophagy in cancer stem cells. FASEB J. 2018;32(S1):804.26–804.26.
   Google Scholar
• Park SY, Kim WJ, Byun JH, et al. Role of DDX53 in taxol-resistance of cervix cancer cells in vitro. Biochem Biophys Res Commun. 2018;506(3):641–647.
   PubMed Web of Science ®Google Scholar
• Holland P, Knævelsrud H, Søreng K, et al. HS1BP3 negatively regulates autophagy by modulation of phosphatidic acid levels. Nat Commun. 2016;7(1):13889.
   PubMedGoogle Scholar
• Bunnell BA, Heath LS, Adams DE, et al. Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. Proc Natl Acad Sci U S A. 1990;87(19):7467–7471.
   PubMed Web of Science ®Google Scholar
• Wilkinson S, Croft DR, O’Prey J, et al. The cyclin-dependent kinase PITSLRE/CDK11 is required for successful autophagy. Autophagy. 2011;7(11):1295–1301.
   PubMed Web of Science ®Google Scholar
• Blasco-Moreno B, de Campos-Mata L, Böttcher R, et al. The exonuclease Xrn1 activates transcription and translation of mRNAs encoding membrane proteins. Nat Commun. 2019;10(1):1298.
   PubMedGoogle Scholar
• Delorme-Axford E, Abernathy E, Lennemann NJ, et al. The exoribonuclease Xrn1 is a post-transcriptional negative regulator of autophagy. Autophagy. 2018;14(5):898–912.
   PubMed Web of Science ®Google Scholar
• Neeper M, Schmidt AM, Brett J, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem. 1992;267(21):14998–15004.
   PubMed Web of Science ®Google Scholar
• Kang R, Tang D, Schapiro NE, et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ. 2010;17(4):666–676.
   PubMed Web of Science ®Google Scholar
• Kang R, Tang D, Lotze MT, et al. RAGE regulates autophagy and apoptosis following oxidative injury. Autophagy. 2011;7(4):442–444.
   PubMed Web of Science ®Google Scholar
• Alves ALV, Costa AM, Martinho O, et al. WNK2 inhibits autophagic flux in human glioblastoma cell line. Cells. 2020;9(2):485.
   PubMed Web of Science ®Google Scholar
• Tao YF, Li ZH, Du WW, et al. Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation. Oncol Rep. 2017;37(3):1419–1429.
   PubMed Web of Science ®Google Scholar
• Muller-Tidow C, Bug G, Lubbert M, et al. A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia. Br J Haematol. 2013;163(2):214–222.
   PubMed Web of Science ®Google Scholar
• Kozyreva VK, Kiseleva AA, Ice RJ, et al. Combination of eribulin and aurora A inhibitor MLN8237 prevents metastatic colonization and induces cytotoxic autophagy in breast cancer. Mol Cancer Ther. 2016;15(8):1809–1822.
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy J, McIntyre K, Wilks S, et al. Efficacy and safety of weekly paclitaxel with or without oral alisertib in patients with metastatic breast cancer: a randomized clinical trial. JAMA Network Open. 2021;4(4):e214103.
   PubMed Web of Science ®Google Scholar
• Falchook G, Coleman RL, Roszak A, et al. Alisertib in combination with weekly paclitaxel in patients with advanced breast cancer or recurrent ovarian cancer: a randomized clinical trial. JAMA Oncol. 2019;5(1):e183773.
   PubMed Web of Science ®Google Scholar